James F. Young, Director at NOVAVAX INC (NVAX), sold 11,000 shares at $112.98 ($1.2M) on 2020-12-31, disclosed to the SEC on 2021-01-05.
Open-market sale of $1.2M NVAX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $112.98 | 9,000 | $1.0M | 81.7% |
| 2 | $113.60 | 2,000 | $227K | 18.3% |
| Total | $113.09 avg | 11,000 | $1.2M | 100% |
| Filing → |
| NVAX | SELL | 2024-06-21 | $190K | — | Filing → |
| NVAX | SELL | 2022-04-04 | $1.8M | — | Filing → |
| NVAX | SELL | 2022-01-04 | $541K | — | Filing → |